Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of levetiracetam in preparing intelligence benefiting medicament

A technology of use, medicine, applied in the field of medicine

Inactive Publication Date: 2008-05-07
BEIJING RUNDEKANG MEDICAL TECH CO LTD
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The mechanism of antiepileptic action is different from that of other antiepileptic drugs. It mainly binds to the special receptor in the brain-synaptic vesicle protein SV2A, which has central selectivity and regulates neurotransmission by participating in vesicle aggregation and effervescence The mechanism of action above the level of this receptor is still under further study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of levetiracetam in preparing intelligence benefiting medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 tablet

[0038] prescription:

[0039] components

Dosage

Levetiracetam

starch

Magnesium stearate

CMS-Na

90% ethanol

Co-made

500g

35g

5g

10g

Appropriate amount

1000 pieces

[0040] Tablets are prepared according to conventional preparation techniques.

[0041] Usage: Take orally, 1-2 tablets each time, 2-3 times a day

Embodiment 2

[0042] Embodiment 2: capsules

[0043] prescription:

[0044] components

Dosage

levatin

microcrystalline cellulose

Micropowder silica gel

90% ethanol

Co-made

500g

20g

5g

Appropriate amount

1000 capsules

[0045] Capsules are prepared according to the conventional preparation process.

[0046] Usage: Take orally, 1-2 capsules each time, 2-3 times a day

Embodiment 3

[0047] Example 3: Chewable Tablets

[0048] prescription:

[0049] components

Dosage

Levetiracetam

Xylitol

Sorbitol

Sweet Orange Flavor

500g

200

250

15g

[0050] aspartame

2% PVP-k30 ethanol solution

Co-made

15g

Appropriate amount

1000 pieces

[0051] Chewable tablets are prepared according to the conventional preparation process.

[0052] Usage: Take orally, 1-2 tablets each time, 2-3 times a day

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the purpose of Levetiracetam during the process of preparing galangal medicine, the Levetiracetam is anti-epilepsia medicine with good curative effect at present, because the Levetiracetam and the structure of the naoyizhi medicine piracetam have large similarity, the invention aims at exploring the function of the Levetiracetam on the aspect of Naoyizhi. The invention is to find out therapeutic medicine with more obvious, safer and more reliable curative effect for intelligence damage caused by a cerebrovascular disease. The normal taking dosage of the Levetiracetam is 500 to 1500 mg / time. 2 to 3 times for one day, the Levetiracetam and auxiliary materials which can be accepted on the pharmacy can be produced into oral tablets, capsules and pelletized granules.

Description

technical field [0001] The invention relates to the use of levetiracetam in the preparation of nootropics, belonging to the technical field of medicine. Background technique [0002] Cerebrovascular disease is also known as cerebrovascular accident, cerebral apoplexy or stroke. It is a group of diseases characterized by the loss of local neurological function caused by the disturbance of blood circulation in the brain. Seen in middle-aged and elderly people. After a cerebrovascular accident, there are often dysfunctions in the form of paralysis, aphasia, agnosia, and dementia, and various degrees of sequelae, which not only cause great pain to the person, but also bring a heavy burden to the family. . [0003] Cerebrovascular disease with a large scope or multiple recurrences may leave mental and intellectual disabilities. It manifests as decreased memory and calculation power, unresponsiveness, inability to read and write, and finally develops into dementia. Even eatin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/40A61P25/28A61P25/00
Inventor 陈瑞晶
Owner BEIJING RUNDEKANG MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com